Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors With P53 Deficiency

Molecular Therapy - Oncolytics - United Kingdom
doi 10.1016/j.omto.2019.12.013
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

USP11 Regulates P53 Stability by Deubiquitinating P53

Journal of Zhejiang University: Science B
GeneticsPharmacologyMolecular BiologyBiochemistryVeterinaryMedicineToxicologyPharmaceutics
2014English

An Inhibitor of the Proteasomal Deubiquitinating Enzyme USP14 Induces Tau Elimination in Cultured Neurons

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Testosterone as Potential Effective Therapy in Treatment of Obesity in Men With Testosterone Deficiency: A Review

Current Diabetes Reviews
EndocrinologyMetabolismDiabetes
2012English

Combined PPARg Activation and XIAP Inhibition as a Potential Therapeutic Strategy for Ovarian Granulosa Cell Tumors

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Blocking P53 Aggregation Restores Its Activity and Suppresses Tumors

Cancer Discovery
Oncology
2016English

The Therapeutic Potential of Deubiquitinating Enzyme Inhibitors

Biochemical Society Transactions
Biochemistry
2010English

Stem Cells as a Potential Therapy for Epilepsy

Experimental Neurology
Developmental NeuroscienceNeurology
2013English

Itga4 Inhibition by Mir-30d as a Potential Target in Relapsing Form of MS Therapy

International Journal of Human Genetics
Genetics
2018English

NPM1 as a Potential Therapeutic Target for Atypical Teratoid/Rhabd Tumors

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy